Measurement of neuropsychiatric symptoms in clinical trials targeting Alzheimer's disease and related disorders

Pharmaceuticals

Volumn 3, Issue 8, 2010, Pages 2387-2397

  David, Renaud ^a   Mulin, Emmanuel ^a   Mallea, Patrick ^a   Robert, Philippe H ^a  

^a University of Côte d'Azur   (France)

Author keywords

Actigraphy; Alzheimer's disease; Assessment tools; Clinical trials; Neuropsychiatric symptoms

Indexed keywords

ACTIMETRY; ALZHEIMER DISEASE; APATHY; ARTICLE; AUTOMATION; BEHAVIOR DISORDER; BIOSENSOR; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; GLOBAL POSITIONING SYSTEM; HUMAN; MEDICAL TECHNOLOGY; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SYMPTOMATOLOGY;

EID: 77955577234     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3082387     Document Type: Article

References (56)

1. Robert, P.H.; Verhey, F.R.; Byrne, E.J.; Hurt, C.; De Deyn, P.P.; Nobili, F.; Riello, R.; Rodriguez, G.; Frisoni, G.B.; Tsolaki, M.; Kyriazopoulou, N.; Bullock, R.; Burns, A.; Vellas, B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur. Psychiatry 2005, 20, 490-496.
2. Steinberg, M.; Shao, H.; Zandi, P.; Lyketsos, C.G.; Welsh-Bohmer, K.A.; Norton, M.C.; Breitner, J.C.; Steffens,D.C.; Tschanz, J.T. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int. J. Geriatr. Psychiatry 2008, 23, 170-177.
3. Perrault, A.; Oremus, M.; Demers, L.; Vida, S.; Wolfson, C. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J. Geriatr. Psychiatry Neuro. 2000, 13, 181-196.
4. Forester, B.P.; Oxman, T.E. Measures to Assess the Noncognitive Symptoms of Dementia in the Primary Care Setting. Prim. Care Companion J. Clin. Psychiatry 2003, 5, 158-163.
5. Cummings, J.L. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 1997, 48 (Suppl. 6), S10-S16.
6. Ownby, R.L.; Koss, E.; Smyth, K.A.; Whitehouse, P.J. The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 1994, 7, 245-250.
7. Mack, J.L.; Patterson, M.B. The evaluation of behavioral disturbances in Alzheimer's disease: the utility of three rating scales. J. Geriatr. Psychiatry Neurol. 1994, 7, 99-115.
8. Rosen, W.G.; Mohs, R.C.; Davis, K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984, 141, 1356-1364.
9. Reisberg, B.; Auer, S.R.; Monteiro, I.M. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int. Psychogeriatr 1996, 8 (Suppl. 3), 301-308; discussion 351-354.
10. Harwood, D.G.; Ownby, R.L.; Barker, W.W.; Duara, R. The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients. Int. J. Geriatr. Psychiatry 1998, 13, 793-800.
11. Raskin, A.; Crook, T.; Relative's Assessment of Global Symptomatology (RAGS). Psychopharmacol. Bull. 1988, 24, 7597-7763.
12. Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 1997, 11 (Suppl. 2), S40-S44.
13. Baumgarten, M.; Becker, R.; Gauthier, S. Validity and reliability of the dementia behavior disturbance scale. J. Am. Geriatr. Soc. 1990, 38, 221-226.
14. Robert, P.; Verhey, F.R.J.; Aalten, P.; Cortes, F.; Byrne, E.J. Neuropsychiatric outcome for clinical trials. J. Nutr. Health Aging 2007, 11, 345-347.
15. Aalten, P.; Verhey, F.R.; Boziki, M.; Bullock, R.; Byrne, E.J.; Camus, V.; Caputo, M.; Collins, D.; De Deyn, P.P.; Elina, K.; Frisoni, G.; Girtler, N.; Holmes, C.; Hurt, C.; Marriott, A.; Mecocci, P.; Nobili, F.; Ousset, P.J.; Reynish, E.; Salmon, E.; Tsolaki, M.; Vellas, B.; Robert, P.H. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement. Geriatr. Cogn. Disord. 2007, 24, 457-463.
16. Connor, D.J.; Sabbagh, M.N.; Cummings, J.L. Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials. Alzheimers Dement. 2008, 4, 390-394.
17. Lebert, F.; Pasquier, F.; Souliez, L.; Petit, H. Frontotemporal behavioral scale. Alzheimer Dis. Assoc. Disord. 1998, 12, 335-339.
18. Kertesz, A.; Davidson, W.; Fox, H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can. J. Neurol. Sci. 1997, 24, 29-36.
19. Cohen-Mansfield, J. Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument. Int. Psychogeriatr. 1996, 8 (Suppl. 3), 309-315; discussion, 351-354.
20. Alexopoulos, G.S.; Abrams, R.C.; Young, R.C.; Shamoian, C.A. Cornell scale for depression in dementia. Biological Psychiatry 1988, 23, 271-284.
21. Yesavage, J.A.; Brink, T.L.; Rose, T.L. Development and validation of a geriatric depression scale: a preliminary report. J. Psychiatry Res. 1983, 17, 37-49.
22. Marin, R.S.; Biedrzycki, R.C.; Firinciogullari, S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991, 38, 143-162.
23. Starkstein, S.E.; Mayberg, H.S.; Preziosi, T.J.; Andrezejewski, P.; Leiguarda, R.; Robinson, R.G. Reliability, validity and clinical correlates of apathy in Parkinsons's disease. J. Neuropsychiatry Clin. Neurosci. 1992, 4, 134-139.
24. Robert, P.H.; Clairet, S.; Benoit, M.; Koutaich, J.; Bertogliati, C.; Tible, O.; Caci, H.; Borg, M.; Brocker, P.; Bedoucha, P. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int. J. Geriatr. Psych. 2002, 17, 1099-1105.
25. Sockeel, P.; Dujardin, K.; Devos, D.; Denève, C.; Destée, A.; Defebvre, L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's Disease. J. Neurol. Neurosur. Psychiatry 2006, 77, 579-584.
26. De Medeiros, K.; Robert, P.; Gauthier, S.; Politis, A.; Stella, F.; Leotskakos, J.; Taragano, F.; Kremer, J.; Brugnolo, A.; Porteinsson, A.; Geda, Y.; Brodaty, H.; Lyketsos, C. The NPI-C: A clinician-rated Assessment of Neuropsychiatric Symptoms in Dementia. In IPA International Congress, Montreal, QC Canada 1-5 September 2009.
27. Jeste, D.V.; Finkel, S.I. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am. J. Geriatr. Psychiatry 2000, 8, 29-34.
28. Olin, J.T.; Schneider, L.S.; Katz, I.R.; Meyers, B.S.; Alexopoulos, G.S.; Breitner, J.C.; Bruce, M.L.; Caine, E.D.; Cummings, J.L.; Devanand, D.P.; Krishnan, K.R.; Lyketsos, C.G.; Lyness, J.M.; Rabins, P.V.; Reynolds, C.F. 3rd.; Rovner, B.W.; Steffens, D.C.; Tariot, P.N.; Lebowitz, B.D. Provisional diagnostic criteria for depression of Alzheimer disease. Am. J. Geriatr. Psychiatry 2002, 10, 125-128.
29. Robert, P.; Onyike, C.U.; Leentjens, A.F.; Dujardin, K.; Aalten, P.; Starkstein, S.; Verhey, F.R.; Yessavage, J.; Clement, J.P.; Drapier, D.; Bayle, F.; Benoit, M.; Boyer, P.; Lorca P.M.; Thibaut, F.; Gauthier, S.; Grossberg, G.; Vellas, B.; Byrne, J. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur. Psychiatry 2009, 24, 98-104.
30. Mulin, E.; Leone, E.; Dujardin, K.; Delliaux, M.; Leentjens, A.F.; Nobili, F.; Dessi, B.; Tible, O.; Aguera-Ortiz, L.; Osorio, R.; Yesavage, J.; Verhey, F.; Blanc, O.; Llorca, P.; Robert, P. Diagnostic cirteria for apathy in clinical practice. Int. J. Geriatr. Psychiatry 2010, in submission.
31. Kupfer, D.J.; Detre, T.P.; Foster, G.; Tucker, G.J.; Delgado, J. The application of Delgado's telemetric mobility recorder for human studies. Behav. Biol. 1972, 7, 585-590.
32. McPartland, R.J.; Foster, F.G.; Kupfer, D.J.; Weiss, B.L. Activity sensors for use in psychiatric evaluation. IEEE Trans. Biomed. Eng. 1976, 23, 175-178.
33. Ancoli-Israel, S.; Clopton, P.; Klauber, M.R.; Fell, R.; Mason, W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997, 20, 24-27.
34. Yesavage, J.A.; Friedman, L.; Kraemer, H.C.; Noda, A.; Wicks, D.; Bliwise, D.L.; Sheikh, J.; Tinklenberg, J.; Zarcone, V. A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients. J. Geriatr. Psychiatry Neurol. 1998, 11, 7-10.
35. Dane, A.V.; Schachar, R.J.; Tannock, R. Does actigraphy differentiate ADHD subtypes in a clinical research setting? J. Am. Acad. Child Adolesc. Psychiatry 2000, 39, 752-760.
36. Kemlink, D.; Pretl, M.; Sonka, K.;Nevsimalova, S.; A comparison of polysomnographic and actigraphic evaluation of periodic limbmovements in sleep. Neurol. Res. 2007, 30, 234-238.
37. Sadeh, A.; Hauri, P.J.; Kripke, D.F.; Lavie, P. The role of actigraphy in the evaluation of sleep disorders. Sleep 1995, 18, 288-302.
38. Cole, R.J.; Kripke, D.F.; Gruen, W.; Mullaney, D.J.; Gillin, J.C. Automatic sleep/wake identification from wrist activity. Sleep 1992, 15, 461-469.
39. Nagels, G.; Engelborghs, S.; Vloeberghs, E.; Van Dam, D.; Pickut, B.A.; De Deyn, P.P. Actigraphic measurement of agitated behaviour in dementia. Int. J. Geriatr. Psychiatry 2006, 21, 388-393.
40. Mahlberg, R.; Walther, S. Actigraphy in agitated patients with dementia: Monitoring treatment outcomes. Z. Gerontol Geriatr. 2007, 40, 178-184.
41. Mahlberg, R.; Walther, S.; Eichmann, U.; Tracik, F.; Kunz, D. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Arch. Gerontol. Geriatr. 2007, 45, 19-26.
42. Volkers, A.C.; Tulen, J.H.; Duivenvoorden, H.J.; Gieteling, M.J.; Wegewijs-De Jong, M.; Van Den Broek, W.W.; Passchier, J.; Pepplinkhuizen, L. Effect of personality dimensions on the diurnal pattern of motor activity. J. Pers. 2002, 70, 233-247.
43. Volkers, A.C.; Tulen, J.H.; Van Den Broek, W.W.; Bruijn, J.A.; Passchier, J.; Pepplinkhuizen, L. 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder. Eur. Neuropsychopharmacol. 2002, 12, 273-278.
44. Volkers, A.C.; Tulen, J.H.; van den Broek, W.W.; Bruijn, J.A.; Passchier, J.; Pepplinkhuizen, L. Motor activity and autonomic cardiac functioning in major depressive disorder. J. Affect Disord. 2003, 76, 23-30.
45. Muller, U.; Czymmek, J.; Thone-Otto, A.; Von Cramon, D.Y. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj. 2006, 20, 157-160.
46. David, R.; Rivet, A.; Robert, P.H.; Mailland, V.; Friedman, L.; Zeitzer, J.M.; Yesavage, J. Ambulatory Actigraphy correlates with apathy in Mild Alzheimer's disease. Dementia 2009, in press.
47. Robert, P.H.; Clairet, S.; Benoit, M.; Koutaich, J.; Bertogliati, C.; Tible, O.; Caci, H.; Borg, M.; Brocker, P.; Bedoucha, P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int. J. Geriatr. Psychiatry 2002, 17, 1099-1105.
48. David, R.; Mulin, E.; Robert, P. Actigraphic assessment of apathy in Alzheimer's disease. World J. Biol. Psychiatry 2009, 10 (Suppl. 1), 42-43.
49. Banerjee, S.; Steenkeste, F.; Couturier, P.; Debray, M.; Franco, A. Telesurveillance of elderly patients by use of passive infra-red sensors in a 'smart' room. J. Telemed. Telecare 2003, 9, 23-29.
50. David, R.; Colazzo, G.; Siccardi, L.; Forcellino, L.; Vada, A.; Louchart, S.; Serrati, C.; Piva, M.; Robert, P. Evaluation of apathy using attentional reaction test in neurodegenerative diseases. Eur. Psychiat. 2008, 23 (Suppl. 2), 193.
51. Shoval, N.; Auslander, G.K.; Freytag, T.; Landau, R.; Oswald, F.; Seidl, U.; Wahl, H.W.; Werner, S.; Heinik, J. The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases. BMC Geriatr. 2008, 8, 7.
52. Sink, K.M.; Holden, K.F.; Yaffe, K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005, 293, 596-608.
53. Ancoli-Israel, S.; Amatniek, J.; Ascher. S.; Sadik, K.; Ramaswamy, K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis. Assoc. Disord. 2005, 19, 240-245.
54. Mahlberg, R.; Kunz, D.; Sutej, I.; Kuhl, K.P.; Hellweg, R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J. Clin. Psychopharmacol. 2004, 24, 456-459.
55. Singer, C.; Tractenberg, R.E.; Kaye, J.; Schafer, K.; Gamst, A.; Grundman, M.; Thomas, R.; Thal, L.J. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003, 26, 893-901.
56. Gehrman, P.R.; Connor, D.J.; Martin, J.L.; Shochat, T.; Corey-Bloom, J.; Ancoli-Israel, S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 2009, 17, 166-169.